Speciality: Infectious diseases
Description:
A warm welcome to all the medical professionals in this interesting session on Omicron: What to know about this new COVID-19 variant? - By Dr. Preeti Parmar
Dr. Preeti Parmar provides a comprehensive overview of Omicron, a new COVID-19 variant that has become a significant concern globally. Identified first in South Africa in late 2021, Omicron is notable for its extensive
mutations in the spike protein, which impact the virus's transmissibility and immune evasion capabilities.
Omicron's high number of mutations has made it more transmissible than previous variants. Dr. Parmar explains that this has led to rapid increases in case numbers worldwide, even in populations with high vaccination rates. While early data suggests that Omicron may result in milder illness compared to the Delta variant, its enhanced spread poses substantial risks, especially to healthcare systems already burdened by the pandemic.
Vaccination remains a key strategy in combating Omicron. Dr. Parmar highlights that booster doses significantly improve protection against this variant, reinforcing the need for booster
campaigns. Moreover, she stresses the importance of maintaining other public health measures such as mask-wearing, social distancing, and regular testing to control its spread.
Therefore, get an overall knowledge of omicron: what to know about this new covid-19 variant? - By Dr. Preeti Parmar
See More Webinars @ Hidoc Webinars
1.
Study opens up possibility of bespoke prostate cancer treatment
2.
Why Encouragement May Not Improve Motivation in Depression
3.
Study Finds Actionable Mutations in Brain Mets of Breast Cancer Patients
4.
A person's susceptibility to papillary thyroid cancer may be determined by variations in telomere lengthening genes.
5.
Pirtobrutinib May Be Beneficial in Follicular Lymphoma with Severe Pretreatment.
1.
Prevention Through Survivorship-Focused Strategies for Preserving Functional Independence After Cancer
2.
Patient Management for Bone Marrow Functional Recovery Pathways
3.
Uncovering the Causes of Thrombocytosis: A Journey to Improved Health
4.
Targeted Approaches to Breast Cancer Liver Metastases: Surgery, Ablation, and Survival Insights
5.
Hematopoietic Immune Microenvironment Plasticity: Mechanisms, Clinical Implications, and Emerging Therapeutics
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
2.
Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.
3.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV
4.
Early Cancer Detection Saves Lives
5.
How Platelet Disorders Can Affect the Body
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation